Literature DB >> 28508967

A case of xanthinuria type I with a novel mutation in xanthine dehydrogenase.

Akira Iguchi1, Takaaki Sato2, Mihoko Yamazaki2, Kazuyuki Tasaki2, Yasushi Suzuki2, Noriaki Iino3, Hiroshi Hasegawa4, Kimiyoshi Ichida4, Ichiei Narita5.   

Abstract

Hereditary hypouricemia is generally caused by renal hypouricemia, an autosomal recessive disorder that is characterized by impaired renal tubular uric acid transport, or by xanthinuria, a rare autosomal recessive disorder caused by a deficiency of xanthine dehydrogenase (XDH; xanthinuria type I) or by a deficiency of both XDH and aldehyde oxidase (xanthinuria type II). In contrast to renal hypouricemia, which sometimes leads to exercise-induced acute kidney injury (EIAKI), xanthinuria has not been associated with this disorder. We report here a case of xanthinuria type I due to a compound heterozygous mutation. A 46-year-old woman was found to have undetectable plasma and urinary levels of uric acid. She had no symptoms and no history of EIAKI. Xanthinuria type I was diagnosed following the allopurinol loading test. Mutation analysis revealed a compound heterozygous mutation [c.305A>G (p.Gln102Arg) and c.2567delC (p.Thr856Lysfs*73)] in the XDH gene. Of these two mutations, the former is novel. The patient did not exhibit EIAKI. However, because xanthinuria is a rare disease, the identification of additional cases is necessary to determine whether this disease is complicated with EIAKI.

Entities:  

Keywords:  Exercise-induced acute kidney injury; Hypouricemia; Xanthine oxidase; Xanthinuria

Year:  2016        PMID: 28508967      PMCID: PMC5413754          DOI: 10.1007/s13730-016-0216-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  24 in total

Review 1.  Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature.

Authors:  T Ohta; T Sakano; T Ogawa; J Kato; Y Awaya; H Kihara; Y Kinoshita
Journal:  Clin Nephrol       Date:  2002-10       Impact factor: 0.975

2.  Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II.

Authors:  K Ichida; T Matsumura; R Sakuma; T Hosoya; T Nishino
Journal:  Biochem Biophys Res Commun       Date:  2001-04-20       Impact factor: 3.575

3.  Two siblings with classical xanthinuria type 1: significance of allopurinol loading test.

Authors:  K Ichida; M Yoshida; R Sakuma; T Hosoya
Journal:  Intern Med       Date:  1998-01       Impact factor: 1.271

4.  Molecular identification of a renal urate anion exchanger that regulates blood urate levels.

Authors:  Atsushi Enomoto; Hiroaki Kimura; Arthit Chairoungdua; Yasuhiro Shigeta; Promsuk Jutabha; Seok Ho Cha; Makoto Hosoyamada; Michio Takeda; Takashi Sekine; Takashi Igarashi; Hirotaka Matsuo; Yuichi Kikuchi; Takashi Oda; Kimiyoshi Ichida; Tatsuo Hosoya; Kaoru Shimokata; Toshimitsu Niwa; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Nature       Date:  2002-04-14       Impact factor: 49.962

5.  Biochemical studies on the purine metabolism of four cases with hereditary xanthinuria.

Authors:  T Kojima; T Nishina; M Kitamura; T Hosoya; K Nishioka
Journal:  Clin Chim Acta       Date:  1984-02-28       Impact factor: 3.786

6.  Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria.

Authors:  Faysal Gok; Kimiyoshi Ichida; Rezan Topaloglu
Journal:  Nephrol Dial Transplant       Date:  2003-11       Impact factor: 5.992

7.  Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene.

Authors:  K Ichida; Y Amaya; K Noda; S Minoshima; T Hosoya; O Sakai; N Shimizu; T Nishino
Journal:  Gene       Date:  1993-11-15       Impact factor: 3.688

8.  Hypoxanthine and xanthine levels determined by high-performance liquid chromatography in plasma, erythrocyte, and urine samples from healthy subjects: the problem of hypoxanthine level evolution as a function of time.

Authors:  R Boulieu; C Bory; P Baltassat; C Gonnet
Journal:  Anal Biochem       Date:  1983-03       Impact factor: 3.365

9.  Xanthine dehydrogenase deficiency with novel sequence variations presenting as rheumatoid arthritis in a 78-year-old patient.

Authors:  Agnieszka Jurecka; Blanka Stiburkova; Jakub Krijt; Wanda Gradowska; Anna Tylki-Szymanska
Journal:  J Inherit Metab Dis       Date:  2010-01-14       Impact factor: 4.982

10.  Functional characterization of human xanthine oxidase allelic variants.

Authors:  Mutsumi Kudo; Toshiko Moteki; Takamitsu Sasaki; Yumiko Konno; Shuta Ujiie; Akemi Onose; Michinao Mizugaki; Masaaki Ishikawa; Masahiro Hiratsuka
Journal:  Pharmacogenet Genomics       Date:  2008-03       Impact factor: 2.089

View more
  5 in total

1.  Hereditary xanthinuria in a goat.

Authors:  Krystal J Vail; Nicole M Tate; Tasha Likavec; Katie M Minor; Philippa M Gibbons; Raquel R Rech; Eva Furrow
Journal:  J Vet Intern Med       Date:  2019-02-13       Impact factor: 3.333

2.  Xanthine Oxidoreductase Inhibitors Suppress the Onset of Exercise-Induced AKI in High HPRT Activity Urat1-Uox Double Knockout Mice.

Authors:  Takuji Hosoya; Shunya Uchida; Shigeru Shibata; Naoko H Tomioka; Koji Matsumoto; Makoto Hosoyamada
Journal:  J Am Soc Nephrol       Date:  2021-11-19       Impact factor: 10.121

Review 3.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

4.  Renal stone and chronic kidney failure associated with hypouricemia: Answers.

Authors:  Gulsah Kaya Aksoy; Mustafa Koyun; Kimiyoshi Ichida; Elif Comak; Sema Akman
Journal:  Pediatr Nephrol       Date:  2018-12-19       Impact factor: 3.714

5.  An ancestral variant causing type I xanthinuria in Turkmen and Arab families is predicted to prevail in the Afro-Asian stone-forming belt.

Authors:  Hava Peretz; Michael Korostishevsky; David M Steinberg; Mustafa Kabha; Sali Usher; Irit Krause; Hannah Shalev; Daniel Landau; David Levartovsky
Journal:  JIMD Rep       Date:  2019-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.